انتقل إلى وضع عدم الاتصال باستخدام تطبيق Player FM !
Hema Now: Episode 8: What’s Next in Lymphoma Diagnosis and Treatment?
Manage episode 461128298 series 3412919
This week, Jonathan is joined by Marc Hoffman, Associate Professor in Hematologic Malignancies and Cellular Therapeutics at the University of Kansas Medical Center, to discuss novel therapies for B-cell malignancies and current challenges in hemato-oncology.
Timestamps:
(00:00)-Introduction
(03:24)-What is molecular biophysics?
(07:01)-Marc’s journey into hemato-oncology
(09:36)-Advice to young doctors
(13:08)-Treatment advances in diffuse large B-cell lymphoma
(19:11)-BRUIN study: pirtobrutinib for B-cell malignancies
(26:15)-Challenges in CAR-T therapy implementation
(31:31)-A pharmaceutical perspective
(38:10)-Regulatory insights into clinical trials
(40:58)-New horizons in hemato-oncology
(44:26)-Marc’s three wishes for healthcare
200 حلقات
Manage episode 461128298 series 3412919
This week, Jonathan is joined by Marc Hoffman, Associate Professor in Hematologic Malignancies and Cellular Therapeutics at the University of Kansas Medical Center, to discuss novel therapies for B-cell malignancies and current challenges in hemato-oncology.
Timestamps:
(00:00)-Introduction
(03:24)-What is molecular biophysics?
(07:01)-Marc’s journey into hemato-oncology
(09:36)-Advice to young doctors
(13:08)-Treatment advances in diffuse large B-cell lymphoma
(19:11)-BRUIN study: pirtobrutinib for B-cell malignancies
(26:15)-Challenges in CAR-T therapy implementation
(31:31)-A pharmaceutical perspective
(38:10)-Regulatory insights into clinical trials
(40:58)-New horizons in hemato-oncology
(44:26)-Marc’s three wishes for healthcare
200 حلقات
كل الحلقات
×مرحبًا بك في مشغل أف ام!
يقوم برنامج مشغل أف أم بمسح الويب للحصول على بودكاست عالية الجودة لتستمتع بها الآن. إنه أفضل تطبيق بودكاست ويعمل على أجهزة اندرويد والأيفون والويب. قم بالتسجيل لمزامنة الاشتراكات عبر الأجهزة.